The association between C-reactive protein-triglyceride glucose index and all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a single-center retrospective cohort study - Scorecard - MDSpire
Advertisement
The association between C-reactive protein-triglyceride glucose index and all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a single-center retrospective cohort study
Clinical Scorecard: The Relationship Between C-Reactive Protein-Triglyceride Glucose Index and Overall Mortality in Individuals with Cardiovascular-Kidney-Metabolic Syndrome: A Retrospective Cohort Analysis from a Single Center
At a Glance
Category
Detail
Condition
Cardiovascular-Kidney-Metabolic Syndrome
Key Mechanisms
Integration of inflammation and insulin resistance
Target Population
Patients with CKM syndrome
Care Setting
Retrospective cohort study
Key Highlights
CTI is an independent predictor of all-cause mortality in CKM patients.
Higher CTI quartiles correlate with increased mortality risk.
CTI shows superior predictive performance over TyG index.
A linear dose-response relationship exists between CTI and mortality.
Study included 8,632 CKM patients with 860 deaths (10.0%).
Guideline-Based Recommendations
Diagnosis
CKM syndrome staged according to AHA criteria.
Management
Utilization of CTI for risk stratification in CKM patients.
Monitoring & Follow-up
Regular assessment of CTI levels to evaluate mortality risk.
Risks
Increased mortality risk associated with higher CTI levels.
Patient & Prescribing Data
Adults (age ≥ 18 years) with CKM syndrome.
CTI may guide tailored interventions to improve outcomes.
Clinical Best Practices
Incorporate CTI in routine assessments for CKM patients.
Monitor inflammatory and metabolic markers in CKM management.
